UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

Journal of the American College of Cardiology, 2008-09, Vol.52 (12), p.997-1003

2008

Volltextzugriff (PDF)

Slowing the Progression of Cardiovascular Disease

Journal of the American College of Cardiology, 2016-04, Vol.67 (14), p.1698-1700

Cohn, Jay N., MD

2016

Volltextzugriff (PDF)

Prevention of cardiovascular disease

Trends in cardiovascular medicine, 2015-07, Vol.25 (5), p.436-442

Cohn, Jay N., MD

2015

Volltextzugriff (PDF)

Trials and Tribulations

Journal of cardiac failure, 2016-03, Vol.22 (3), p.180-181

Cohn, Jay N., MD

2016

Volltextzugriff (PDF)

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

Journal of cardiac failure, 2010-12, Vol.16 (12), p.964-970

2010

Volltextzugriff (PDF)

Time to Foster a Rational Approach to Preventing Cardiovascular Morbid Events

Journal of the American College of Cardiology, 2008-07, Vol.52 (5), p.327-329

2008

Volltextzugriff (PDF)

Unconventional End Points in Cardiovascular Clinical Trials: Should We Be Moving Away From Morbidity and Mortality?

Journal of cardiac failure, 2009-04, Vol.15 (3), p.199-205

2009

Volltextzugriff (PDF)

Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction

The American heart journal, 2012-08, Vol.164 (2), p.259-267

2012

Volltextzugriff (PDF)

Endothelial Nitric Oxide Synthase (NOS3) Polymorphisms in African Americans With Heart Failure: Results From the A-HeFT Trial

Journal of cardiac failure, 2009-04, Vol.15 (3), p.191-198

2009

Volltextzugriff (PDF)

Identifying the Risk and Preventing the Consequences of Cardiovascular Disease

Heart, lung & circulation, 2013-07, Vol.22 (7), p.512-516

Cohn, Jay N., MD

2013

Volltextzugriff (PDF)

Preventing Heart Failure: A Critique of Strategies

Journal of cardiac failure, 2013-04, Vol.19 (4), p.211-213

Cohn, Jay N., MD

2013

Volltextzugriff (PDF)

What’s in a Name?

Journal of cardiac failure, 2012, Vol.18 (3), p.175-175

Cohn, Jay N., MD

2012

Volltextzugriff (PDF)

Reply

Journal of cardiac failure, 2012, Vol.18 (6), p.513-513

Cohn, Jay N., MD

2012

Volltextzugriff (PDF)

Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure Trial

Journal of the American College of Cardiology, 2007-01, Vol.49 (1), p.32-39

2007

Volltextzugriff (PDF)

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

Journal of cardiac failure, 2007-12, Vol.13 (10), p.797-804

2007

Volltextzugriff (PDF)

G-Protein Beta-3 Subunit Genotype Predicts Enhanced Benefit of Fixed-Dose Isosorbide Dinitrate and Hydralazine

JACC. Heart failure, 2014-12, Vol.2 (6), p.551-557

2014

Volltextzugriff (PDF)

Detecting the Patient at Risk of Heart Failure

Journal of the American College of Cardiology, 2010-05, Vol.55 (19), p.2138-2139

Cohn, Jay N., MD

2010

Volltextzugriff (PDF)

Isosorbide Dinitrate and Hydralazine in a Fixed-Dose Combination Produces Further Regression of Left Ventricular Remodeling in a Well-Treated Black Population With Heart Failure: Results From A-HeFT

Journal of cardiac failure, 2007-06, Vol.13 (5), p.331-339

2007

Volltextzugriff (PDF)

Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial

Journal of cardiac failure, 2012-08, Vol.18 (8), p.600-606

2012

Volltextzugriff (PDF)

Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial

Journal of cardiac failure, 2009-12, Vol.15 (10), p.835-842

2009

Volltextzugriff (PDF)

Myocardial Structural Effects of Aldosterone Receptor Antagonism in Heart Failure

Journal of the American College of Cardiology, 2007-08, Vol.50 (7), p.597-599

Cohn, Jay N., MD, FACC

2007

Volltextzugriff (PDF)

Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT)

The American heart journal, 2011-07, Vol.162 (1), p.154-159

2011

Volltextzugriff (PDF)

Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations

Journal of the American Society of Hypertension, 2011-09, Vol.5 (5), p.401-409

2011

Volltextzugriff (PDF)

Conflicts of Interest: To Eliminate Them or Manage Them

Journal of cardiac failure, 2009-06, Vol.15 (5), p.375-376

Cohn, Jay N., MD

2009

Volltextzugriff (PDF)

Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction

Journal of the American College of Cardiology, 2007-04, Vol.49 (13), p.1450-1458

2007

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)

Slowing the Progression of Cardiovascular Disease

Prevention of cardiovascular disease

Trials and Tribulations

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

Time to Foster a Rational Approach to Preventing Cardiovascular Morbid Events

Unconventional End Points in Cardiovascular Clinical Trials: Should We Be Moving Away From Morbidity and Mortality?

Underuse of cardiovascular preventive pharmacotherapy in patients presenting with ST-elevation myocardial infarction

Endothelial Nitric Oxide Synthase (NOS3) Polymorphisms in African Americans With Heart Failure: Results From the A-HeFT Trial

Identifying the Risk and Preventing the Consequences of Cardiovascular Disease

Preventing Heart Failure: A Critique of Strategies

What’s in a Name?

Reply

Influence of Blood Pressure on the Effectiveness of a Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine in the African-American Heart Failure Trial

Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial

G-Protein Beta-3 Subunit Genotype Predicts Enhanced Benefit of Fixed-Dose Isosorbide Dinitrate and Hydralazine

Detecting the Patient at Risk of Heart Failure

Isosorbide Dinitrate and Hydralazine in a Fixed-Dose Combination Produces Further Regression of Left Ventricular Remodeling in a Well-Treated Black Population With Heart Failure: Results From A-HeFT

Effect of Fixed-Dose Combined Isosorbide Dinitrate/Hydralazine in Elderly Patients in the African-American Heart Failure Trial

Relationship of Quality of Life Scores With Baseline Characteristics and Outcomes in the African-American Heart Failure Trial

Myocardial Structural Effects of Aldosterone Receptor Antagonism in Heart Failure

Atrial fibrillation and mortality in African American patients with heart failure: Results from the African American Heart Failure Trial (A-HeFT)

Vascular and cardiac functional and structural screening to identify risk of future morbid events: preliminary observations

Conflicts of Interest: To Eliminate Them or Manage Them

Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction

Suchergebnisse filtern